Bringing the fundamentals into focus…
Back to AbCellera Biologics Inc.
How AbCellera Biologics Inc. stacks up
ABCL · against 264 other Healthcare companies of similar size
Profitability
10/ 100
Near the bottom of its peers.
Ranked #245 of 265 · scores higher than 7% of peers
Bars: peers in each 10-point band of the profitability score20 peers with a profitability score of 10–19, including ABCL · Click a bar to see the companies
Why profitability scores 10?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 92% of peers. Operating margin: -340.3% vs peer median 7.1%
- a lower return on invested capital: weaker than 80% of peers. Return on invested capital: -22.9% vs peer median 4.7%
- a lower return on assets: weaker than 77% of peers. Return on assets: -12.6% vs peer median 1.7%
Metric by metric
Position: dot = ABCL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ABCL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 255 reported | -22.9% | 8.1% | 17% | 33% | |
| Operating marginHigher is better · 241 reported | -340.3% | 10.3% | 6% | 33% | |
| Return on assetsHigher is better · 252 reported | -12.6% | 3.0% | 20% | 33% | |
| Return on equityHigher is better · 248 reported | -17.3% | 7.4% | 25% | Context only | |
| Gross marginHigher is better · 272 reported | -198.9% | 47.5% | 0% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around ABCL| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 4 | 3.8B USD | 99 | 71 | |
| 241 | 3.4B USD | 12 | 35 | |
| 241 | 5.1B USD | 12 | 35 | |
| 241 | 2.2B USD | 12 | 35 | |
| 244 | 2.2B USD | 11 | 48 | |
| 245 | 3.9B USD | 10 | 47 | |
| 245 | 6.2B USD | 10 | 44 | |
| 245 | 3.0B USD | 10 | 11 | |
| 248 | 7.7B USD | 9 | 36 | |
| 248 | 3.3B USD | 9 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score